BACKGROUND: In Africa, human immunodeficiency virus (HIV)-infected patients who present to care with CD4 levels >350 cells/µL (ie, current antiretroviral treatment thresholds) are often thought to be poorly retained in care, but most estimates do not account for outcomes among patients lost to follow-up. METHODS: We evaluated HIV-infected adults who had made a visit in the last 2.5 years in a program in Uganda. We identified a random sample of patients lost to follow-up (9 months without a visit). Ascertainers sought patients in the community in this sample and outcomes were incorporated into revised survival estimates of mortality and retention for the clinic population using a probability weight. RESULTS: Of 6473 patients, (29% male, median age 29 years, median CD4 count 550 cells/µL), 1294 (20%) became lost to follow-up over 2.5 years. Two hundred seven (16%) randomly selected lost patients were sought, and in 175 (85%) vital status was ascertained. In 19 of 175 (11%), the patient had died. Of the 156 (89%) alive, 74 (47%) were interviewed in person, and 38 of 74 (51%) reported HIV care elsewhere, whereas 36 of 74 (49%) were not in care. Application of weights derived from sampling found that at 2.5 years, retention among patients who enrolled with CD4 levels >350 cells/µL was 88.2% and mortality was 2.5%. Lower income, unemployment, and rural residence were associated with failure to be retained. CONCLUSIONS: Retention in patients entering care with high CD4 counts under routine program conditions in Africa is high in a Ugandan care program and may be systematically underestimated in many other settings.
BACKGROUND: In Africa, human immunodeficiency virus (HIV)-infectedpatients who present to care with CD4 levels >350 cells/µL (ie, current antiretroviral treatment thresholds) are often thought to be poorly retained in care, but most estimates do not account for outcomes among patients lost to follow-up. METHODS: We evaluated HIV-infected adults who had made a visit in the last 2.5 years in a program in Uganda. We identified a random sample of patients lost to follow-up (9 months without a visit). Ascertainers sought patients in the community in this sample and outcomes were incorporated into revised survival estimates of mortality and retention for the clinic population using a probability weight. RESULTS: Of 6473 patients, (29% male, median age 29 years, median CD4 count 550 cells/µL), 1294 (20%) became lost to follow-up over 2.5 years. Two hundred seven (16%) randomly selected lost patients were sought, and in 175 (85%) vital status was ascertained. In 19 of 175 (11%), the patient had died. Of the 156 (89%) alive, 74 (47%) were interviewed in person, and 38 of 74 (51%) reported HIV care elsewhere, whereas 36 of 74 (49%) were not in care. Application of weights derived from sampling found that at 2.5 years, retention among patients who enrolled with CD4 levels >350 cells/µL was 88.2% and mortality was 2.5%. Lower income, unemployment, and rural residence were associated with failure to be retained. CONCLUSIONS: Retention in patients entering care with high CD4 counts under routine program conditions in Africa is high in a Ugandan care program and may be systematically underestimated in many other settings.
Authors: Myron S Cohen; Ying Q Chen; Marybeth McCauley; Theresa Gamble; Mina C Hosseinipour; Nagalingeswaran Kumarasamy; James G Hakim; Johnstone Kumwenda; Beatriz Grinsztejn; Jose H S Pilotto; Sheela V Godbole; Sanjay Mehendale; Suwat Chariyalertsak; Breno R Santos; Kenneth H Mayer; Irving F Hoffman; Susan H Eshleman; Estelle Piwowar-Manning; Lei Wang; Joseph Makhema; Lisa A Mills; Guy de Bruyn; Ian Sanne; Joseph Eron; Joel Gallant; Diane Havlir; Susan Swindells; Heather Ribaudo; Vanessa Elharrar; David Burns; Taha E Taha; Karin Nielsen-Saines; David Celentano; Max Essex; Thomas R Fleming Journal: N Engl J Med Date: 2011-07-18 Impact factor: 91.245
Authors: Katie Tayler-Smith; Rony Zachariah; Moses Massaquoi; Marcel Manzi; Olesi Pasulani; Thomas van den Akker; Marielle Bemelmans; Ariane Bauernfeind; Beatrice Mwagomba; Anthony D Harries Journal: Trans R Soc Trop Med Hyg Date: 2010-02-06 Impact factor: 2.184
Authors: Elvin H Geng; David R Bangsberg; Nicolas Musinguzi; Nneka Emenyonu; Mwebesa Bosco Bwana; Constantin T Yiannoutsos; David V Glidden; Steven G Deeks; Jeffrey N Martin Journal: J Acquir Immune Defic Syndr Date: 2010-03 Impact factor: 3.731
Authors: Mari M Kitahata; Stephen J Gange; Alison G Abraham; Barry Merriman; Michael S Saag; Amy C Justice; Robert S Hogg; Steven G Deeks; Joseph J Eron; John T Brooks; Sean B Rourke; M John Gill; Ronald J Bosch; Jeffrey N Martin; Marina B Klein; Lisa P Jacobson; Benigno Rodriguez; Timothy R Sterling; Gregory D Kirk; Sonia Napravnik; Anita R Rachlis; Liviana M Calzavara; Michael A Horberg; Michael J Silverberg; Kelly A Gebo; James J Goedert; Constance A Benson; Ann C Collier; Stephen E Van Rompaey; Heidi M Crane; Rosemary G McKaig; Bryan Lau; Aimee M Freeman; Richard D Moore Journal: N Engl J Med Date: 2009-04-01 Impact factor: 91.245
Authors: Elvin H Geng; David V Glidden; Mwebesa Bosco Bwana; Nicolas Musinguzi; Nneka Emenyonu; Winnie Muyindike; Katerina A Christopoulos; Torsten B Neilands; Constantin T Yiannoutsos; Steven G Deeks; David R Bangsberg; Jeffrey N Martin Journal: PLoS One Date: 2011-07-26 Impact factor: 3.240
Authors: Rory Leisegang; Susan Cleary; Michael Hislop; Alistair Davidse; Leon Regensberg; Francesca Little; Gary Maartens Journal: PLoS Med Date: 2009-12-01 Impact factor: 11.069
Authors: Jonathan A C Sterne; Margaret May; Dominique Costagliola; Frank de Wolf; Andrew N Phillips; Ross Harris; Michele Jönsson Funk; Ronald B Geskus; John Gill; François Dabis; Jose M Miró; Amy C Justice; Bruno Ledergerber; Gerd Fätkenheuer; Robert S Hogg; Antonella D'Arminio Monforte; Michael Saag; Colette Smith; Schlomo Staszewski; Matthias Egger; Stephen R Cole Journal: Lancet Date: 2009-04-08 Impact factor: 79.321
Authors: Constantin T Yiannoutsos; Ming-Wen An; Constantine E Frangakis; Beverly S Musick; Paula Braitstein; Kara Wools-Kaloustian; Daniel Ochieng; Jeffrey N Martin; Melanie C Bacon; Vincent Ochieng; Sylvester Kimaiyo Journal: PLoS One Date: 2008-12-02 Impact factor: 3.240
Authors: D Shankar; A M V Kumar; B Rewari; S Kumar; S Shastri; S Satyanarayana; R Ananthakrishnan; S B Nagaraja; M Devi; N Bhargava; M Das; R Zachariah Journal: Public Health Action Date: 2014-12-21
Authors: Matthew D Burkey; Sheri D Weiser; Desiree Fehmie; Stella Alamo-Talisuna; Pamella Sunday; Joy Nannyunja; Steven J Reynolds; Larry W Chang Journal: J Acquir Immune Defic Syndr Date: 2014-05-01 Impact factor: 3.731
Authors: J Daniel Kelly; Gabriel Warren Schlough; Sulaiman Conteh; M Bailor Barrie; Brima Kargbo; Thomas P Giordano Journal: PLoS One Date: 2016-02-22 Impact factor: 3.240
Authors: Olga Tymejczyk; Quynh Vo; Sarah Gorrell Kulkarni; Gretchen Antelman; Judith Boshe; William Reidy; Angela Parcesepe; Denis Nash; Batya Elul Journal: AIDS Care Date: 2019-12-11
Authors: Jodie Dionne-Odom; Courtney Massaro; Kristen M Jogerst; Zhongze Li; Marie-Marcelle Deschamps; Cleonas Junior Destine; Redouin Senecharles; Moleine Moles Aristhene; Joseph Yves Domercant; Vanessa Rouzier; Peter F Wright Journal: AIDS Res Treat Date: 2016-08-29